- Trials with a EudraCT protocol (185)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
185 result(s) found for: G Proteins.
Displaying page 1 of 10.
EudraCT Number: 2007-003111-31 | Sponsor Protocol Number: 2007-1-18-20-6 | Start Date*: 2008-07-21 |
Sponsor Name:Charité - Universitaetsmedizin Berlin | ||
Full Title: Influence of postoperative influenza vaccination versus GM-CSF in immune-compromised patients undergoing pancreatic or esophageal resection on the course of immunosuppression and the postoperative ... | ||
Medical condition: Post-operative immunological stimulation in severe immune suppression. The study population is made up of adult, which are able to give their inform consent by their own. The patients are undergoin... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002550-32 | Sponsor Protocol Number: VIPES | Start Date*: 2012-12-21 | |||||||||||
Sponsor Name:DBV Technologies SA | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomized trial to study the Viaskin® Peanut’s Efficacy and Safety for treating peanut allergy in children and adults. | |||||||||||||
Medical condition: Treatment of peanut allergy in adults and children age 6 years and older with documented hypersensitivity to peanut. The induction of clinical desensitization to peanut in patients allergic to pean... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) PL (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000317-22 | Sponsor Protocol Number: BRE-ASA01 | Start Date*: 2017-04-13 |
Sponsor Name:Linköping University | ||
Full Title: A pilot study of low dose acetylsalicylic acid (ASA) for reduction of breast density and inflammation | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004012-35 | Sponsor Protocol Number: ALB-INFUS | Start Date*: 2017-01-13 |
Sponsor Name:Medical University of Graz | ||
Full Title: Effect of albumin infusion on oxidative albumin modification, albumin binding capacity and plasma thiol status | ||
Medical condition: refractory ascites, spontaneous bacterial peritonitis, hepatorenal syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001457-18 | Sponsor Protocol Number: 6108K2-2000-ES | Start Date*: 2008-12-15 | |||||||||||
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | |||||||||||||
Full Title: Single-blind, Randomized, Phase 1/2 Trial of the Safety, Tolerability, and Immunogenicity of Meningococcal Group B rLP2086 Vaccine in Healthy Infants | |||||||||||||
Medical condition: Healthy infant vaccination against Meningitis B | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011884-35 | Sponsor Protocol Number: SAKK 77/08 and SASL 29 | Start Date*: 2009-12-19 |
Sponsor Name:Swiss Group for Clinical Cancer Research | ||
Full Title: Sorafenib alone or in combination with everolimus in patients with unresectable hepatocellular carcinoma. A randomized multicenter phase II trial. | ||
Medical condition: Patients with unresectable hepatocellular carcinoma. | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: HU (Ongoing) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002766-20 | Sponsor Protocol Number: CAUY922A2101 | Start Date*: 2009-02-25 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A phase I dose escalation, multi-center, open-label study of AUY922 administered IV on a once-weekly schedule in adult patients with advanced solid malignancies including phase II expansion arms in... | ||
Medical condition: Dose-expansion study to assess safety, tolerability & efficacy: -One arm (MTD expansion) will enroll advanced cancer patients (other than breast carcinoma). -Two arms (phase II) to assess response ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) DE (Prematurely Ended) NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006099-38 | Sponsor Protocol Number: P-piller102 | Start Date*: 2012-08-06 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Effects of an antiandrogenic oral contraceptive on eating behaviour in women with bulimia – A randomized double blinded, placebo controlled study. | ||
Medical condition: Bulimia nervosa is an eating disorder with a prevalence of about 2% in young women (Fairburn and Beglin, 1990). It is characterized by frequent binge eating episodes and the regular use of inapprop... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000882-22 | Sponsor Protocol Number: KARISMAII | Start Date*: 2016-07-11 |
Sponsor Name:Karolinska Institute | ||
Full Title: Karisma II: A randomized, double blinded, six-armed placebo controlled study to imnvestigate optimal dose of tamoxifen with the most favourable side effect spectra and with density reduction non-in... | ||
Medical condition: The mammographic density reduction in healthy women, within the Karma cohort for five different doses of tamoxifen. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001212-29 | Sponsor Protocol Number: Prot-0824-2019 | Start Date*: 2020-08-26 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital, Henrik Birn | ||||||||||||||||||
Full Title: Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome | ||||||||||||||||||
Medical condition: Nephrotic syndrome is defined as severe proteinuria (> 3.5 g / day), edema and hypoalbuminemia. It is conditioned by a defect in the kidney's glomerular filtration barrier, resulting in the loss of... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000126-38 | Sponsor Protocol Number: OVG2012/05 | Start Date*: 2014-04-08 |
Sponsor Name:University of Oxford | ||
Full Title: Towards improved meningococcal vaccines: a randomised, descriptive, open label study exploring the relationship between gene expression signatures with reactogenicity and immunogenicity following v... | ||
Medical condition: This study aims to investigate gene expression following vaccination with 4CMenB and relate this to vaccine reactions and to immune response | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002940-86 | Sponsor Protocol Number: SELLIFA-02 | Start Date*: 2007-08-24 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc – Université catholique de Louvain | |||||||||||||
Full Title: Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and... | |||||||||||||
Medical condition: Liver failure, Liver cirrhosis, critical illness, total nutritional support | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004333-33 | Sponsor Protocol Number: 13HH1771 | Start Date*: 2014-01-20 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Phase 1 of dose escalation of extracorporeal shockwave treatment only and in combination DPP-4 inhibitor and parathyroid hormone (non-randomised, open-labelled) & Phase II of combination treatments... | |||||||||||||
Medical condition: ischaemic cardiomyopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002520-16 | Sponsor Protocol Number: 626 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:Universitätsklinik für klinische Pharmakologie, Medizinische Universität Wien | |||||||||||||
Full Title: The effects of post-conditioning and administration of Vitamin C on intramuscular high energy phosphate levels | |||||||||||||
Medical condition: ischemia reperfusion injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004601-27 | Sponsor Protocol Number: A5481008 | Start Date*: 2013-07-17 |
Sponsor Name:Pfizer Inc | ||
Full Title: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND PHASE 3 STUDY OF PD-0332991 (ORAL CDK 4/6 INHIBITOR) PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ER (+), HER2... | ||
Medical condition: "Estrogen receptor-positive (ER+), HER2 negative (HER2-) Advanced Breast Cancer (ABC)" | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) BE (Completed) IE (Completed) FR (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) HU (Completed) IT (Ongoing) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007134-19 | Sponsor Protocol Number: GAM10-04 | Start Date*: 2009-01-14 |
Sponsor Name:Octapharma AG | ||
Full Title: Prospective 24-week, double-blind, randomized, placebo-controlled, multicenter study evaluating safety and change in efficacy-related surrogate parameters in patients with dementia of the Alzheimer... | ||
Medical condition: mild to moderate Alzheimer´s disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003221-25 | Sponsor Protocol Number: NAC071 | Start Date*: 2008-01-24 | |||||||||||
Sponsor Name:United Lincolnshire Hospitals NHS Trust [...] | |||||||||||||
Full Title: Phase II study of the effectiveness of the addition of Capecitabine to a standard regimen containing Adriamycin, Cyclophosphamide and Docetaxel as neoadjuvant treatment in large or locally advanced... | |||||||||||||
Medical condition: Large (>/=3 cm) or locally advanced breast cancers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000592-17 | Sponsor Protocol Number: MODY-TREAT | Start Date*: 2012-08-03 | |||||||||||
Sponsor Name:Signe H. Østoft, Diabetes Research Division | |||||||||||||
Full Title: The effects of GLP-1 in Maturity- onset diabetes of the young (MODY) | |||||||||||||
Medical condition: 'Maturity onset diabetes of the young', also called 'Hepatocyte nuclear factor 1-alfa daiabetes'. It is a monogenic form of inherited diabetes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006120-20 | Sponsor Protocol Number: 31-06-2011 | Start Date*: 2012-03-15 |
Sponsor Name:University Medical Centre Ljubljana | ||
Full Title: Efficacy and safety of selective vitamin D receptor activation with paricalcitol for reduction of proteinuria in kidney transplant recipients: a randomized controlled trial | ||
Medical condition: Proteinuria in kidney transplant recipients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002909-49 | Sponsor Protocol Number: ONCO 120 | Start Date*: 2007-11-14 | |||||||||||
Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST | |||||||||||||
Full Title: Neoadjuvant chemotherapy in patients affected by prostatic cancer locally advanced (non metastatic. Phase II study | |||||||||||||
Medical condition: Patients with histologically proven prostate adenocarcinoma (non metastatic) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.